BeStock  

Elanco Animal Health ELAN

US equityMarket cap rank #1233Drug Manufacturers - Specialty & Generic
$25.74 −$0.55 (-2.09%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $25.22 -2.04%
Open$26.22
Prev close$26.29
Day range$25.58 – $26.93
Volume5.83M
Market cap$12.87B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.8%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+26.3%
Worst reaction-11.5%

Stock move on the day after each report

-0.7%2023/Q4+24.9%2024/Q1+4.9%2024/Q2+12.8%2024/Q3-3.7%2024/Q4+26.3%2025/Q1+18.1%2025/Q2-4.0%2025/Q3+6.6%2025/Q4+13.9%2026/Q1+2.4%2026/Q2+8.7%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q36 Nov 2026Pre Market±9.7%+8.70%Within range
2026/Q25 Aug 2026Pre Market±11.6%+2.42%Within range
2026/Q16 May 2026Pre Market±9.6%+13.88%Bigger than priced
2025/Q424 Feb 2026Pre Market±10.7%+6.59%Within range
2025/Q35 Nov 2025Pre Market±13.0%-4.00%Within range
2025/Q27 Aug 2025None±12.3%+18.14%Bigger than priced
2025/Q17 May 2025None±11.1%+26.29%Bigger than priced
2024/Q425 Feb 2025None±14.6%-3.69%Within range
2024/Q37 Nov 2024None±10.0%+12.75%Bigger than priced
2024/Q28 Aug 2024None±17.6%+4.93%Within range
2024/Q18 May 2024None±10.5%+24.93%Bigger than priced
2023/Q426 Feb 2024None±11.4%-0.67%Within range
2023/Q37 Nov 2023Pre Market±11.2%+14.32%Bigger than priced
2023/Q27 Aug 2023Pre Market±12.3%+4.03%Within range
2023/Q19 May 2023Pre Market±16.2%-0.53%Within range
2022/Q421 Feb 2023None±13.7%-11.50%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.27B+11.3% YoY
Operating profit$84.00M+211.1% YoY
Net profit$18.00M+152.9% YoY
Diluted EPS$0.04+157.1% YoY
Free cash flow$156.00M+22.8% YoY
Operating cash flow$216.00M

Revenue, last 8 quarters

$1.0BDec '24$1.2BMar '25$1.2BJun '25$1.1BSep '25$1.1BDec '25$1.4BMar '26$1.4BJun '26$1.3BSep '26

Net profit, last 8 quarters

$-8.0MDec '24$67.0MMar '25$11.0MJun '25$-34.0MSep '25$-276.0MDec '25$57.0MMar '26$54.0MJun '26$18.0MSep '26

Profitability & balance sheet

Gross margin56.2%
Operating margin7.6%
Net margin-2.9%
Return on equity-2.2%
Return on assets-1.1%
Return on invested capital0.1%
Current ratio2.09
Liabilities / assets50.3%
Cash & investments$465.00M
Total debt$3.71B
Net cash (debt)-$3.24B
Free cash flow / sales7.9%

Discussion

No comments yet — be the first to weigh in on ELAN.

Sign in to join the discussion.

Scroll to Top